Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

220
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
220
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

251
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
251

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancing Interfacial Charge Transport in Gold Nanoparticle@Polyaniline Hybrids via N-Heterocyclic Carbene Linkers.

Angewandte Chemie (International ed. in English)·2026
Same author

Multi-stakeholder perspectives on gender-based violence in marital relationships: A qualitative study in rural India.

PLOS global public health·2026
Same author

Concepts of psychosocial distress and help-seeking preferences among Indigenous adolescents: A qualitative study from Jharkhand, India.

PLOS mental health·2026
Same author

The association of extracellular vesicle (EV)-cargo miR-330-3p with postoperative delirium and a potential mechanism of tau phosphorylation and neuron toxicity.

bioRxiv : the preprint server for biology·2026
Same author

Resolving Single-Particle Absorption and Scattering by Plasmonic Magnesium Nanoparticles.

Nano letters·2026
Same author

Rare case of primary granulomatous hypophysitis mimicking pituitary macroadenoma: A diagnostic challenge.

Indian journal of pathology & microbiology·2026

Related Experiment Video

Updated: Dec 21, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.3K

Post Transplant Lymphoproliferative Disorder.

Devika Gupta1, Satish Mendonca2, Sushmita Chakraborty3

  • 11Department of Laboratory Science and Molecular Medicine, Army Hospital (Research and Referral), New Delhi, India.

Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|May 20, 2020
PubMed
Summary
This summary is machine-generated.

Posttransplant lymphoproliferative disorder (PTLD) is a fatal complication of immunosuppression. Understanding Epstein-Barr virus (EBV) roles in PTLD pathogenesis and monitoring recipients aids early detection and pre-emptive therapy.

Keywords:
Epstein–Barr virus (EBV)Hematopoietic stem cell transplantImmunosuppressionPost transplant lymphoproliferative disorderRituximabSolid organ transplant

More Related Videos

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.7K
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.3K

Related Experiment Videos

Last Updated: Dec 21, 2025

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation
06:15

Author Spotlight: Investigating the Key Factors of Obliterative Bronchiolitis After Lung Transplantation

Published on: November 10, 2023

1.3K
Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line
12:58

Expression of Exogenous Cytokine in Patient-derived Xenografts via Injection with a Cytokine-transduced Stromal Cell Line

Published on: May 10, 2017

9.7K
Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm
08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

12.3K

Area of Science:

  • Transplant medicine
  • Immunology
  • Oncology

Background:

  • Posttransplant lymphoproliferative disorder (PTLD) is a severe complication in transplant recipients, often linked to Epstein-Barr virus (EBV) and immunosuppression.
  • PTLD incidence is higher in solid organ transplants than hematopoietic stem cell transplants.
  • Pathogenesis involves EBV infection/reactivation and immune dysregulation, with EBV+ PTLDs typically occurring early post-transplant.

Purpose of the Study:

  • To elucidate the pathogenesis of PTLD, differentiating between EBV-associated and EBV-negative forms.
  • To highlight the importance of early detection and pre-emptive strategies for PTLD prevention.
  • To discuss current treatment modalities and challenges in managing PTLD while preventing graft rejection.

Main Methods:

  • Review of PTLD pathogenesis, focusing on the role of Epstein-Barr virus (EBV).
  • Analysis of PTLD incidence and timing based on transplant type and EBV status.
  • Examination of histological patterns and treatment approaches, including immunosuppression reduction and adjuvant therapies.

Main Results:

  • EBV plays a critical role in early-onset PTLDs, while late-onset lymphomas are often EBV-negative.
  • PTLD presents a spectrum of histological patterns, from non-destructive to aggressive polymorphic or monomorphic lesions.
  • Early detection via seropositivity monitoring allows for pre-emptive therapy, though established cases require complex management.

Conclusions:

  • Understanding the pathobiology of EBV+ and EBV- PTLDs is crucial for preventing lymphomagenesis in transplant recipients.
  • Reducing immunosuppression is the primary treatment for established PTLD, supplemented by chemotherapy and immunomodulatory agents.
  • Achieving remission without graft rejection remains a significant challenge, emphasizing the need for improved therapeutic strategies.